Results 181 to 190 of about 14,520 (202)

Fulvestrant

Reactions Weekly
openaire   +2 more sources

Fulvestrant/ribociclib

Reactions Weekly, 2023
openaire   +1 more source

Fulvestrant 500 mg versus anastrozole 1 mg for the first-line treatment of advanced breast cancer: follow-up analysis from the randomized ‘FIRST’ study

Breast Cancer Research and Treatment, 2012
John F R Robertson, Justin P O Lindemann, Antonio Llombart-Cussac   +2 more
exaly  

Fulvestrant and the sequential endocrine cascade for advanced breast cancer

British Journal of Cancer, 2004
Johnston S
exaly  

Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer

New England Journal of Medicine, 2020
Patrick Neven, Stephen Chia, Peter A Fasching   +2 more
exaly  

Fulvestrant

2008
openaire   +1 more source

Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor–positive/human epidermal growth factor receptor 2–negative metastatic breast cancer in PALOMA-3

European Journal of Cancer, 2018
Angela Demichele, Carla Giorgetti, Seock-Ah Im   +2 more
exaly  

Fulvestrant.

2011
openaire   +1 more source

Oral Metronomic Cyclophosphamide and Methotrexate Plus Fulvestrant in Advanced Breast Cancer Patients: A Mono-Institutional Case-Cohort Report

Breast Journal, 2012
Gaetano AURÍLIO, Elisabetta Munzone, Edoardo Botteri   +2 more
exaly  

Fulvestrant/palbociclib

Reactions Weekly, 2020
openaire   +1 more source